ANTX
AN2 Therapeutics Inc
4.90$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -21,335.0% | -21,991.3% | – | – | – | – | – | – | – | – | – | – | |
| – | 517.5% | 517.5% | – | – | – | – | – | – | – | – | – | – | |
| – | 2,790.0% | 2,981.3% | – | – | – | – | – | – | – | – | – | – | |
| – | -1,370.0% | -2,837.5% | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | 525.0% | 32,862.5% | – | – | – | – | – | – | – | – | – | – | |
| – | -0.4% | -0.4% | – | – | – | – | – | – | – | – | – | – | |
| – | -401.3% | 436.3% | – | – | – | – | – | – | – | – | – | – | |
| – | -21,211.3% | 11,307.5% | – | – | – | – | – | – | – | – | – | – | |
| – | -21,335.0% | -21,991.3% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.